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Abstract 
 
A simple and rapid real-time reverse transcription-PCR (RT-PCR) technique using SYBR 
green fluorescence was developed to quantify Zonula Occludens-1 (ZO-1) mRNA expression 
in histamine-treated cultured bovine retinal  microvessel endothelial cells. There was no dif-
ference between the quantity of ZO-1 mRNA expression in histamine-treated (10-7M to 10-9 
M) and untreated bovine retinal endothelial cells at high magnesium levels.  Immunohisto-
chemistry staining and western blot assay unequivocally demonstrated the approximately 
similar levels of ZO-1 protein in both histamine-treated and non-treated endothelial cells at 
high magnesium concentrations. 
 
Introduction 
 
Zonula Occludens-1, a serine phosphorylated protein with 
approximately 225 kDa, is the main peripheral membrane 
protein  associated with tight junctions [1]. There are two 
isoforms of ZO-1, namely, ZO-1 a+ and ZO-1 a- that differ 
by the presence or absence of an 80 amino acid region [2]. 
ZO-1 has been suggested to play a crucial role in the 
regulation of microvascular permeability and develop-
ment of retinopathy in diabetic patients partly due to his-
tamine and other conditions prevalent in diabetes [3, 4]. 
Since evidence suggests that high magnesium concentra-
tions may be beneficial for endothelial function, we were 
particularly interested in ZO-1 expression by endothelial 
cells at high magnesium concentrations. 
 
It this study we developed a simple and precise method to 
quantify ZO-1. Gardner et al used the western blot to 
quantify ZO-1 in histamine-treated bovine retinal capil-
lary endothelial cells [3]. Takeuchi et al. used the conven-
tional reverse transcriptase PCR to study the ZO-1 mRNA 
expression in histamine-treated cultured human nasal 
epithelial cells [5]. In the present study, we developed the 
real-time PCR method which is fast, accurate and sensi-
tive to study the expression of ZO-1 at high concentra-
tions of magnesium ions. To the best of our knowledge, 
this study is the first attempt to quantify the ZO-1 mRNA 
expression using real-time PCR. 
 
Materials and Methods 
 
Bovine Retinal Microvessel Endothelial Cells (BREC) 
 
The BREC line was obtained from VEC Technologies 
(New York) and was cultured according to the protocol 
suggested by the manufacturers. Briefly, the cells were 
cultured in fibronectin (50 μg/ml)-coated flasks and was 
supplemented with MCDB-131 complete medium [6]. 
BREC from the 4th passage were used throughout our 
study. Confluent BREC were treated with different con-
centrations of histamine after tenfold dilutions of a stock 
solution of 0.1M (Sigma Chemical Company, St. Louis).  
 
The above cells were incubated at 37°C for 5 hours with 
5% CO2. The treated and untreated cells were then washed 
with PBS (0.15M) and scraped prior to the isolation of 
total RNA and immunohistochemical staining. 
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Total RNA and mRNA Isolation 
 
Total RNA was isolated from the cells pellet using the 
High Pure RNA Isolation Kit (Roche Diagnostics, Mann-
heim) according to the instruction in the manual. In brief, 
washed cells were spun, resuspended in PBS and lysed 
with lysis-binding buffer. Cells were subsequently treated 
with DNase to remove contaminated genomic DNA and 
the RNA was eluted with the elution buffer. Quality and 
quantity of the extracted RNA were assessed by measur-
ing A260/A280 ratio and the value at A260 nm, respectively. 
We did not use the RiboGreen assay to determine the 
concentration of the RNA since the extracted RNA was 
more than 100 ng/μl [7]. The ZO-1 mRNA isolation was 
performed using the Transcriptor First Strand cDNA Syn-
thesis kit (Roche Diagnostics, Mannheim) according to 
the instruction manual. DNase treatment was performed 
to avoid the co-amplification of genomic  
 
DNA. Random hexamers were  used to isolate the mRNA  
since it primes throughout the  whole length of all the 
RNAs and at the same time allows the reverse transcrip-
tion of the RNAs that do not carry a poly (A) tail. A total 
of two microliter of cDNA were used for real-time RT-
PCR throughout the study. 
 
Real-Time Quantitative RT-PCR   
 
We performed real-time quantitative RT-PCR in a 
LightCycler® 2.0 (Roche Diagnostics, Mannheim), using 
Failsafe Real-time PCR Capillary Premix Selection kit 
according to the instructions in the manual (EPICENTRE, 
Madison). Primers used for the PCR are listed in Table 
1b. The primers were designed using the Primer 3 soft-
ware [8] and FastPCR [9]. For the Primer 3 software, the 
default parameters of the program were applied, except 
Table 1a. PCR conditions  used for real-time PCR 
 
Program Temperature/temperature transition rate 
(°C/s) 
Incubation Time 
Seek temperature Set to temperature correspond to annealing 
temperature of the primers  
 
- 
Initial denaturation 95°C/20.0  60 sec 
35 cycles of: 
Denaturation 95°C/20.0 1 sec 
Annealing 59°C for ZO-1;61°C  for beta-actin/20.0 5 sec 
Extension 72°C/2.0 13 sec 
 
Melting curve analysis at 65°C– 95°C with 0.1°C/s temperature transition rate 
Cooling at 40°C for 30 sec at 20.0°C/s 
 
Table 1b: Primer sequences used in real time PCR 
    
 
Gene (expected 
size of amplicon) 
 
 
Accession Number 
 
Primer Sequences (5’-3’) 
 
 
ZO-1 (211 bp) 
 
AJ313183 
Forward: cga cca gat cct cag ggt aa (Corresponds to 
nucleotide position 40-59 of bovine ZO-1 mRNA)  
Reverse:  tcc ata ggg aga ttc ctt ctc a 
(Corresponds to nucleotide position 250-229 of bovine 
ZO-1 mRNA) 
 
Beta-actin (120 bp) 
 
AY141970 
Forward:  cac cac acc ttc tac aac gag c  
(Corresponds to nucleotide position 298-319 of bovine 
beta-actin mRNA) 
Reverse: ggt ctc gaa cat gat ctg ggt c 
(Corresponds to nucleotide position 417-396 of bovine 
beta-actin mRNA) 
 
18S rRNA (108 bp) 
 
AF176811 
Forward: aaa cgg cta cca cat cca ag 
(Corresponds to nucleotide position 58-77 of bovine 
18S rRNA mRNA) 
Reverse:tac agg gcc tcg aaa gag tc 
(Corresponds to nucleotide position 165-146 of bovine 
18S rRNA mRNA) 
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for the following changes: Product size for ZO-1=200-
250 bp; beta-actin and 18S rRNA =100-150 bp. Primer 
Tm=58-62°C with a max Tm difference of 2.0°C, max self 
and 3’ self complementary= 6.0 and max poly-X=3. For 
the FastPCR software, the highest efficiency ranking of 
the primers, particularly reverse primers were manually 
chosen for the same amplicon size as designed using 
Primer3 software. The amplicon lengths were kept be-
tween 100-300 bp to ensure highest PCR efficiency [10] 
and reproducibility [11].  
 
A preliminary run was performed to determine the opti-
mal premix. The PCR reaction was carried out in a 20.0 
μl final volume. The real-time PCR conditions were as 
follows; 
 
The size of the PCR product was confirmed by agarose 
gel electrophoresis (2% w/v). Melting curve analysis was 
performed at the end of each run to confirm the specificity 
of amplification [12]. The final concentrations of the 
primers used were 0.625 μM for ZO-1 and 0.3125 μM for 
beta-actin and 18SrRNA for both RT-PCR. RT- (samples 
containing RNA which was not reverse transcribed) was 
included to assess the amplification of contaminating ge-
nomic DNA [10].  
 
The acquisition mode was single at the end of each exten-
sion and the measurement of the fluorescence was done at 
530 nm.  
       
Standard Curve Construction and Calculation 
 
The amplified PCR products were purified using GE-
NEALL PCR Purification Kit (General-Biosystem, Seoul) 
sequenced and confirmed its identity against the available 
sequences. A ten-fold serial dilutions of a purified DNA 
were used to construct a standard curve as previously de-
scribed [13, 14]. The dilutions were made to cover the 
range of Cp (Cross-Point or Ct, threshold cycle at which 
the fluorescence rises appreciably above the background 
noise) that included the Cp of target mRNA in the ex-
periment to maximize the accuracy [11]. The mRNA lev-
els were expressed in relative copy numbers normalized 
against beta-actin mRNA. The ΔΔCt was determined us-
ing the method originally described by Stordeur [14]. The 
normalized ratio of ZO-1 in comparison to beta-actin was 
determined by the LightCycler software (Version 3.5).  
 
ZO-1 Immunohistochemistry (IHC) 
 
Scraped BREC cells were spun, washed with PBS and 
fixed in 10% buffered formalin for 3 days. The fixed cells 
were subsequently dehydrated with graded ethanols, 
cleared with xylene and embedded in paraffin. Five μm 
paraffin sections were cut and stained for ZO-1 protein by 
a standard Avidin-Biotin-peroxidase method. Prior to 
staining, the sections were treated with different concen-
trations of proteinase K at varying incubation times to 
determine the optimal conditions. The above method was 
compared with the heat-induced epitope retrieval method 
(microwave). The primary antibody was a rabbit poly-
clonal anti-ZO-1 (Zymed, San Franscisco), which was 
used at a dilution of 1:100-1:200 (v/v) and incubated at 
37°C for 2 hours or 4°C, 18 hours. This antibody is 
known to react with both isoforms of ZO-1. Biotinylated, 
swine anti-rabbit was used as secondary antibody. The 
immunohistochemistry reaction was developed with 3,3'-
diaminobenzidine tetrahydrochloride (Sigma, St Louis) as 
chromogen. The sections were counterstained in Harris’s 
hematoxylin, dehydrated through graded ethanols and 
mounted in DPX (BDH, London). Negative controls were 
performed by replacing the primary antibody with PBS 
and by omitting the secondary antibody. 
 
Results 
 
Preparation of total RNA  
 
Total RNA was prepared from the histamine-treated and 
untreated BREC. All the extracted RNA samples were 
quantified using a spectrophotometer. The mean concen-
tration was 686.6 ± 140.0 μg/ml and the mean A260/A280 
ratio was 1.84± 0.04 (mean ± SD).  
 
 
 
Fig. 1: Agarose  gel electrophoresis (2%, w/v) of bovine 
ZO-1 (lane 1, 211 bp), beta actin (lane 2, 120 bp), and 
18S rRNA (lane 3, 108 bp). M is a 100 bp size marker; 
lanes 4, 5 and 6 are the negative controls  of ZO-1, beta 
actin and 18S rRNA, respectively. Lane 7 is a reagent 
control.  
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Fig. 2: Standard curves of ZO-1 (I) and beta-actin (II). Inserts in each standard curve are the amplification curves (A) 
and melting peak (B) of each transcript. The linearity (1-eror) and PCR efficiency (E) as calculated by the LightCycler 
software was shown. 
  
 
Fig. 3: Amplification curves of ZO-1 (A) and beta-actin (B) in sample (S) and control sample without reversed 
transcribed (RT-) for the assessment of genomic DNA contamination. Inserts are the melting curve analysis of 
the amplifications. 
 
Primer design and specificity 
 
Primer for ZO-1, beta-actin and 18S rRNA was designed 
using Primer3 and FastPCR software, and analyzed with 
free primer analysis software, NetPrimer (www. premier-
biosoft.com/ netprimer/netprlaunch/ netprlaunch). The 
ZO-1 primers designed by Primer3 gave better results 
than that by FastPCR. However, the primers for beta-actin 
designed by FastPCR produced less primer-dimers than 
that  designed by Primer3. Primers for 18S rRNA were 
equally good using both software (unpublished observa-
tions).  
 
The designed primers were blasted with nucleotide 
BLAST (blastn, NCBI) [15] which resulted in highest 
score (bits) and lowest E value, indicating specificity of 
the primers. The available bovine mRNA partial sequence 
of ZO-1 share 93% similarity with that of human and lo-
cated upstream of the 240 bp spilicing region (motif-α) of  
the ZO-1 mRNA transcript (unpublished data). Hence, the 
designed ZO-1 primers were unable to differentiate both 
isoforms.  
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Fig. 4: Immunohistochemistry staining of ZO-1 in (A)normal,  (B)histamine-treated  at 10-7M, 
in (C)histamine-treated bovine retinal microvessel endothelial cells. (C)Occasionally nuclear localiza-   
tion of ZO-1 could be seen, especially at the free edge of cells (arrows) and in the proximity of apoptotic-
like cells (arrowhead). Insert showed the higher magnification. No immunoreactivity of ZO-1 was seen in 
control negative (D). 
 
Ideally, the primers for the transcript should anneal with 
different exons or on an intron-exon junction to avoid the 
co-amplification of genomic DNA. Since the complete 
genome of the investigated transcripts was  not available 
it was not possible to design such primers. DNase treat-
ment was then performed, as recommended in the manual  
to prevent the genomic DNA contamination. The specific-
ity of the PCR products was determined using gel electro-
phoresis, which resulted in a single product with the ex-
pected lengths (ZO-1, 211 bp; beta-actin, 120 bp and 18S 
rRNA, 108 bp) (figure 1). Melting curve analysis of the 
samples also resulted in a mean melting temperature, Tm 
= 82.73 ± 0.10 for ZO-1 and Tm = 88.31 ± 0.06 for beta-
actin (mean ± SD). In our study, 18S rRNA was highly 
expressed (Cp= ~ 4-5) and could not be determined by the 
LightCycler software. Since the histamine had no effect 
on the beta actin (see later), it was used for normalization  
while quantifying ZO-1 for the subsequent analysis.  
 
Real-time PCR amplification efficiencies and linearity 
 
The PCR efficiency (E) of ZO-1 and beta-actin were 2.03 
and 2.06, respectively with high Pearson correlation coef-
ficient, R2 (1-error) = 0.993 for both transcripts as calcu-
lated by the LightCycler software Version 3.5(figure 2). 
 
Real-time quantitative RT-PCR 
 
Table 2 showed the results obtained by real-time PCR. No 
change in ZO-1 mRNA expression was apparent since the 
fold of change (normalized ratio) was less than 2-folds. In 
order for the differences to be significant, at least two-fold 
changes in normalized ratio in mRNA expression (up-
regulation) or 0.5 (down-regulation) must be taken into 
consideration [16]. 
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Table 2: Relative copy numbers of ZO-1 normalized against beta-actin, was calculated using 
the formulae described by Stordeur et al. [14], for the different concentrations of histamine 
treatment. The normalizedratio was calculated by the LightCycler Software (Version, 3.5) 
with untreated BREC as a calibrator. 
 
 
Treatment 
 
Relative copy numbers of ZO-1 (%) 
(Stordeur et al. 2002) 
 
Normalized ratio 
(LightCycler Software, Version 3.5) 
 
 
10-7M His 
 
104.17 
 
0.96 
 
10-8M His 
 
107.78 
 
1.11 
 
10-9M His 
 
110.00 
 
1.12 
 
 
Validation with Housekeeping Gene  
 
Housekeeping gene allows normalization by standardiz-
ing the differing amounts of RNA, variation in nucleic 
acid  recovery,  pipetting  errors,  RNA  degradation,  and  
variation in cDNA synthesis. Ideally, housekeeping gene  
should remain invariant throughout the biological treatm-
ent and should have the similar expression level as the 
investigated RNA. Increasing number of reports have 
shown the effect of various treatments on the housekeep- 
ing genes [11,18-20]. Therefore, the validation of house-
keeping gene is crucial to the accuracy of data. In our 
study, beta-actin and 18SrRNA were chosen as the 
housekeeping genes and the effect of histamine on them 
were examined. There was no difference between the his-
tamine-treated and in the untreated BREC since the cross 
point values between them were similar (Cp beta-actin = 
13.64 ± 0.13, mean ± SD, n=5). It was not possible to 
calculate the Cp values of 18S rRNA by the software be-
cause of the high expression values (Cp~4-5). The Cp 
values were similar across the histamine treatment and in 
normal BREC, indicating no effect of histamine to the 
18S rRNA expression (unpublished observations). For the 
subsequent studies, we used only beta-actin as housekeep-
ing gene to normalize the ZO-1 since it is invariant 
throughout the histamine treatment and its Cp value was 
closer to ZO-1. 
 
Immunohistochemistry of ZO-1 Protein 
 
In order to determine the correlation between the ZO-1 
mRNA expression and ZO-1 protein levels, we performed 
the immunohistochemical staining of ZO-1 protein in the 
paraffin sections. ZO-1 immunoperoxidase staining was  
treated with different concentrations of Proteinase K at 
varying incubation times to obtain  maximum staining. 
We also microwaved the slides at a high temperature at 
different times and compared the staining with that of 
Proteinase K. A combination of microwave and Pro-
teinase k were used in another set of slides. The optimal 
staining was obtained by Proteinase K treatment at 3 
μg/ml (final concentration) for 15 minute at 37°C. Incu-
bation step of ZO-1 primary antibody (dilution 1:100-
1:200 v/v) either at 4°C for 18 hours or at 37°C for 2 
hours gave the same results. Combination of Microwave 
followed by Proteinase K had no advantages (unpublished 
data). The ZO-1 immunoreactivity was mainly seen in 
apical and apicolateral of the membrane of fibroblast-like 
BREC cells, in the cytoplasm and occasionally in the nu-
cleus (arrows in figure 3). The latter was seen exclusively 
at the free-edge of an island of cells and in the proximity 
of apoptotic-like bodies. The same nuclear accumulation 
of ZO-1 has been described by Gottardi et al. [21]. Inter-
estingly, the fragmented nuclei of the apoptotic-like bod-
ies also showed the immunoreactivity of ZO-1 (insert, 
figure 4 C). The significant of this finding is unknown. It 
is crucial that the cell density is high to obtain optimal 
staining and also to be aware that the staining could be 
different because of the different levels of exposure to the 
antigen. It was difficult to quantitate the staining since  
staining was not confined to one cell, and because the 
pattern of staining could be in diffused-type due to differ-
ent planar sectioning. Although there could be some dif-
ferences in BREC treated with different concentrations of 
histamine, nevertheless, no apparent difference was noted 
between normal and histamine-treated BREC in term of 
staining intensity and area of positivity at the concentra-
tion of magnesium used (Figure 4). 
 
Discussion  
 
In the present study, we developed a real-time RT-PCR 
method  to study the ZO-1 mRNA expression in hista-
mine-treated bovine retinal microvascular endothelial 
cells. Quantification of ZO-1 mRNA expression by con-
ventional reverse transcriptase PCR has been described by 
Takeuchi et al. [5]. However, the real-time approach off-
ers several advantages to study the gene expression comp-
ared to the conventional reverse transcriptase PCR. The 
method is simple, fast and does not require post-PCR ma-
nipulation. 
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To validate the results from real-time quantitative RT-
PCR, we did an immunohistochemical staining on the 
cultured cells. The ZO-1 protein levels were the same for 
the different concentrations of histamine, indicating nei-
ther up-regulation nor down-regulation of ZO-1 mRNA 
expression. Some reports suggested that the protein levels 
correlated with the mRNA expression, while others were 
unable to prove the correlation [22-24]. In our study the  
results obtained from the immunohistochemical staining 
were in good agreement with that of mRNA expression.  
Gardner et al. developed an in vitro system with retinal 
microvascular endothelial cells that mimicked the human 
environment of the eye [3]. They used standard Modified 
Eagle’s medium that contained 0.07mM of magnesium. 
Takeuchi et al. used 0.7 mM Mg2+ in their study [5]. In 
our study, however, we used the complete medium 
MCDB-131 which contains 10mM magnesium [6]. The 
concentration of magnesium in our medium was more 
than that used by Gardner et al. and Takeuchi et al [5]. 
Magnesium has been reported to attenuate histamine-
induced bronchoconstriction in asthmatic patients [25]. 
Magnesium is also known to be a natural suppressor of 
histamine action. We have demonstrated that at high 
magnesium concentrations histamine has little effect on 
the expression of ZO-1.  
 
In conclusion, we have developed a simple and fast quan-
titative real-time RT-PCR for ZO-1 mRNA quantifica-
tion. This technique should be of particular interest for 
those quantifying the ZO-1 mRNA and could provide an 
insight into the role of ZO-1 in the regulation of micro-
vascular permeability.  
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